National Pension Service Purchases 14,937 Shares of Clorox Co (NYSE:CLX)

National Pension Service increased its position in Clorox Co (NYSE:CLX) by 9.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 165,269 shares of the company’s stock after buying an additional 14,937 shares during the quarter. National Pension Service owned 0.13% of Clorox worth $25,304,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in CLX. Asset Management One Co. Ltd. lifted its position in Clorox by 8.7% in the second quarter. Asset Management One Co. Ltd. now owns 105,868 shares of the company’s stock valued at $16,211,000 after purchasing an additional 8,439 shares during the last quarter. O Shares Investment Advisers LLC lifted its position in Clorox by 6.3% in the second quarter. O Shares Investment Advisers LLC now owns 6,604 shares of the company’s stock valued at $1,011,000 after purchasing an additional 391 shares during the last quarter. Bontempo Ohly Capital Mgmt LLC lifted its position in Clorox by 0.9% in the second quarter. Bontempo Ohly Capital Mgmt LLC now owns 16,113 shares of the company’s stock valued at $2,467,000 after purchasing an additional 149 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in Clorox by 8.8% in the second quarter. Nomura Asset Management Co. Ltd. now owns 87,118 shares of the company’s stock valued at $13,338,000 after purchasing an additional 7,026 shares during the last quarter. Finally, Pinebridge Investments L.P. lifted its position in Clorox by 76.9% in the second quarter. Pinebridge Investments L.P. now owns 134,718 shares of the company’s stock valued at $20,627,000 after purchasing an additional 58,556 shares during the last quarter. Institutional investors own 78.20% of the company’s stock.

Several analysts have weighed in on CLX shares. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a research report on Monday, July 29th. ValuEngine downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley boosted their price objective on Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a research report on Friday, August 2nd. Citigroup set a $156.00 price objective on Clorox and gave the company a “hold” rating in a research report on Thursday, May 23rd. Finally, Wells Fargo & Co reiterated a “hold” rating and issued a $153.00 price objective on shares of Clorox in a research report on Thursday, August 1st. Three analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $154.07.

In related news, SVP Michael R. Costello sold 3,225 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total value of $520,321.50. Following the sale, the senior vice president now directly owns 29,669 shares of the company’s stock, valued at $4,786,796.46. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director A D. David Mackay sold 3,400 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total value of $526,558.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,609 shares of company stock worth $2,497,443. 1.40% of the stock is owned by insiders.

Shares of Clorox stock traded down $0.81 during midday trading on Thursday, reaching $154.99. 30,443 shares of the company’s stock traded hands, compared to its average volume of 901,179. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. The company has a market cap of $19.52 billion, a PE ratio of 24.54, a price-to-earnings-growth ratio of 4.85 and a beta of 0.38. The stock has a 50 day moving average of $158.87 and a 200-day moving average of $156.17. Clorox Co has a 12 month low of $141.53 and a 12 month high of $167.70.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The firm’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.66 earnings per share. On average, equities analysts anticipate that Clorox Co will post 6.4 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 30th will be paid a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, October 29th. This represents a $4.24 annualized dividend and a yield of 2.74%. Clorox’s payout ratio is 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: What is Cost of Debt?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.